Gilbert综合征诊断进展*

doi:10.3969/j.issn.1672-5069.2026.03.003

摘要/Abstract

Key words: Gilbert's syndrome, Diagnosis, Differential diagnosis, Jaundice

李美涵, 於海天, 郑素军. Gilbert综合征诊断进展^*[J]. 实用肝脏病杂志, 2026, 29(3): 328-331.

Li Meihan, Yu Haitian, Zheng Sujun. Gilbert's syndrome: current landscape and future perspective[J]. Journal of Practical Hepatology, 2026, 29(3): 328-331.

[1] Fretzayas A, Moustaki M, Liapi O, et al. Gilbert syndrome. Eur J Pediatr. 2012,171(1):11-15.
[2] 中华医学会肝病学分会遗传代谢性肝病协作组.遗传性高胆红素血症诊疗专家共识(2025年版).中华肝脏病杂志,2025, 33(8): 747-759.
[3] Wagner KH, Shiels RG, Lang CA, et al. Diagnostic criteria and contributors to Gilbert's syndrome. Crit Rev Clin Lab Sci, 2018,55(2):129-139.
[4] Stanbridge AJ, Cranshaw T, Paul MM. Clozapine metabolism may be affected by Gilbert's syndrome: case report and discussion. Pharmacogenet Genomics, 2021,31(9):221-224.
[5] Radu P, Atsmon J. Gilbert's syndrome--clinical and pharmacological implications. Isr Med Assoc J, 2001,3(8):593-598.
[6] Zhang D, Chando TJ, Everett DW, et al. In vitro inhibition of UDP glucuronosyltransferases by atazanavir and other HIV protease inhibitors and the relationship of this property to in vivo bilirubin glucuronidation. Drug MetabDispos, 2005,33(11):1729-1739.
[7] Vítek L, Tiribelli C. Gilbert's syndrome revisited. J Hepatol, 2023,79(4):1049-1055.
[8] Bosma PJ, Chowdhury JR, Bakker C, et al. The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome. N Engl J Med, 1995,333(18):1171-1175.
[9] Claridge LC, Armstrong MJ, Booth C, et al. Gilbert's syndrome. BMJ, 2011,342:d2293.
[10] Hsieh TY, Shiu TY, Chu NF, et al. Rapid molecular diagnosis of the Gilbert's syndrome-associated exon 1 mutation within the UGT1A1 gene. Genet Mol Res, 2014,13(1):670-679.
[11] Wagner KH, Shiels RG, Lang CA, et al. Diagnostic criteria and contributors to Gilbert's syndrome. Crit Rev Clin Lab Sci, 2018,55(2):129-139.
[12] 张梦, 李维娜, 陈广, 等. UGT1A1基因检测在Gilbert综合征中的诊断价值分析. 中华肝脏病杂志, 2021, 29(2): 143-149.
[13] King D, Armstrong MJ. Overview of Gilbert's syndrome. Drug Ther Bull, 2019,57(2):27-31.
[14] Poynard T, Deckmyn O, Peta V, et al. Clinical and genetic definition of serum bilirubin levels for the diagnosis of Gilbert syndrome and hypobilirubinemia. Hepatol Commun, 2023,7(10):e0245.
[15] Thomsen HF, Hardt F, Juhl E. Diagnosis of Gilbert's syndrome. Reliability of the caloric restriction and phenobarbital stimulation tests. Scand J Gastroenterol, 1981,16(5):699-703.
[16] Dickey W, McAleer JJ, Callender ME. The nicotinic acid provocation test and unconjugated hyperbilirubinaemia. Ulster Med J, 1991,60(1):49-52.
[17] 张梦. UGT1A1基因检测在Gilbert综合征中的诊断价值分析--附115例Gilbert综合征病例分析.湖北:华中科技大学,2019.
[18] 桑伟,柯比努尔·吐尔逊,马倩,等.Gilbert综合征临床病理诊断及特征分析.新疆医学,2024,54(3):259-262.
[19] Grant LM, Faust TW, Thoguluva Chandrasekar V, et al. Gilbert syndrome. In: StatPearls. Treasure Island (FL): StatPearls Publishing; October 5, 2024.
[20] 冯家立,章莉莎.259例Gilbert综合征UGT1A1基因检测分析.中西医结合肝病杂志,2022,32(12):1127-1129.
[21] 梁晨,罗磊,白洁,等. Gilbert综合征和Crigler-Najjar综合征相关尿苷二磷酸葡糖醛酸转移酶A1基因突变位点特征分析.中华肝脏病杂志,2020,28(5):428-433.
[22] Sun L, Li M, Zhang L, et al. Differences in UGT1A1 gene mutations and pathological liver changes between Chinese patients with Gilbert syndrome and Crigler-Najjar syndrome type II. Medicine (Baltimore),2017,96(45):e8620.
[23] 邓玉婷,魏民华,周俊英.Gilbert综合征研究进展.实用肝脏病杂志,2021,24(2):156-159.
[24] Gu L, Han Y, Zhang D, et al. Genetic testing of UGT1A1 in the diagnosis of Gilbert syndrome: The discovery of seven novel variants in the Chinese population. Mol Genet Genomic Med, 2022,10(7):e1958.
[25] 宁会彬, 李宽, 毛重山, 等. 慢性乙型肝炎合并Gilbert综合征患者33例临床及其基因突变分析.中华肝脏病杂志, 2015, 23(1): 13-16.
[26] 张杰, 郑素军. 溶血性黄疸的临床特征及鉴别诊断. 临床肝胆病杂志, 2020, 36(6): 1423-1427.
[27] He BJ, Liao L, Deng ZF, et al. Molecular genetic mechanisms of hereditary spherocytosis: Current perspectives. Acta Haematol, 2018,139(1):60-66.
[28] Wu Y, Liao L, Lin F. The diagnostic protocol for hereditary spherocytosis-2021 update. J Clin Lab Anal, 2021,35(12):e24034.
[29] Zamora EA, Schaefer CA. Hereditary spherocytosis. In: StatPearls. Treasure Island (FL): StatPearls Publishing; July 4, 2023.
[30] Haley K. Congenital hemolytic anemia. Med Clin North Am, 2017,101(2):361-374.
[31] Nannelli C, Bosman A, Cunningham J, et al. Genetic variants causing G6PD deficiency: Clinical and biochemical data support new WHO classification. Br J Haematol,2023,202(5):1024-1032.
[32] Kaplan M. Genetic interactions in the pathogenesis of neonatal hyperbilirubinemia: Gilbert's syndrome and glucose-6-phosphate dehydrogenase deficiency. J Perinatol, 2001,21 (Suppl 1):S30-S39.
[33] Luzzatto L, Nannelli C, Notaro R. Glucose-6-phosphate dehydrogenase deficiency. Hematol Oncol Clin North Am, 2016,30(2):373-393.
[34] Harcke SJ, Rizzolo D, Harcke HT. G6PD deficiency: An update. JAAPA, 2019,32(11):21-26.
[35] 《地中海贫血携带者筛查及防控专家共识》制订组,肖波. 地中海贫血携带者筛查及防控专家共识. 国际神经病学神经外科学杂志,2024,51(5):43-50.
[36] Viprakasit V, Ekwattanakit S. Clinical classification, screening and diagnosis for thalassemia. Hematol Oncol Clin North Am, 2018,32(2):193-211.
[37] 何俊,赵美英.红细胞参数、红细胞脆性试验及G6PD活性检测在地中海贫血诊断中的应用. 中国医药导刊,2010,12(6):1031-1032.
[38] Ali S, Mumtaz S, Shakir HA, et al. Current status of beta-thalassemia and its treatment strategies. Mol Genet Genomic Med. 2021,9(12):e1788.
[39] 江峰锦,白乐,余泽波,等.自身免疫性溶血性贫血的诊疗进展.临床输血与检验,2023,25(5):692-698.
[40] Powell LW, Hemingway E, Billing BH, et al. Idiopathic unconjugated hyperbilirubinemia (Gilbert's syndrome). A study of 42 families. N Engl J Med, 1967,277(21):1108-1112.
[41] Aono S, Adachi Y, Uyama E, et al. Analysis of genes for bilirubin UDP-glucuronosyltransferase in Gilbert's syndrome. Lancet, 1995,345(8955):958-959.
[42] Bosma P, Chowdhury JR, Jansen PH. Genetic inheritance of Gilbert's syndrome. Lancet, 1995,346(8970):314-315.
[43] Admin.Your genes and why you have gilbert’s syndrome[EB/OL]. (2023-14)[2025-01-21]. https://gilbertssyndrome.org.uk/genes-gilberts-syndrome/.
[44] Maruo Y, Nakahara S, Yanagi T, et al. Genotype of UGT1A1 and phenotype correlation between Crigler-Najjar syndrome type II and Gilbert syndrome. J Gastroenterol Hepatol, 2016,31(2):403-408.
[45] Schonfeld EA, Brown RS Jr. Genetic causes of liver disease: When to suspect a genetic etiology, initial lab testing, and the basics of management. Med Clin North Am, 2019,103(6):991-1003.
[46] Bal C, Chawla M. Hyperthyroidism and jaundice. Indian J Nucl Med, 2010,25(4):131-134.
[47] Piantanida E, Ippolito S, Gallo D, et al. The interplay between thyroid and liver: implications for clinical practice. J Endocrinol Invest, 2020,43(7):885-899.
[48] 郑敏,潘莉珍,谢莉,等.先天性甲状腺功能减低症伴病理性黄疸61例分析.中国优生与遗传杂志,2013,21(5):134-135.
[49] 黄国英,孙锟,罗小平,等.儿科学.10版.北京:人民卫生出版社,2023.
[50] Gou Y, Wang P, Yang W, et al. A Case of adult hereditary spherocytosis concomitant with Gilbert syndrome Caused by mutations in SPTB and UGT1A1. J Inflamm Res,2024,17:5977-5983.

Gilbert综合征诊断进展^*

Gilbert's syndrome: current landscape and future perspective

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	刘建晓, 王燕, 陈世成, 董月稳, 刘向芹, 薛云, 王天赐, 张凯. CT肝细胞外基质体积分数联合血清NOX2和YKL-40水平评估慢性乙型肝炎肝纤维化程度价值研究^*[J]. 实用肝脏病杂志, 2026, 29(3): 337-340.
[2]	赵迎娣, 陈钰婷, 宗富强. Fibroscan评估非酒精性脂肪性肝病患者肝脏脂肪变性程度应用研究^*[J]. 实用肝脏病杂志, 2026, 29(3): 345-348.
[3]	曾浩, 李兵, 雷婷, 李顺华, 李孜. FibroScan检测和CT肝脾比值诊断非酒精性脂肪性肝病肝内脂肪分级价值研究^*[J]. 实用肝脏病杂志, 2026, 29(3): 357-360.
[4]	杨茜, 杨冰冰, 王许, 蒋国宁, 聂婧怡, 杨婧妍, 礼广森. 第一阶段射血分数联合LVEF和GLS诊断肝硬化心肌病价值研究[J]. 实用肝脏病杂志, 2026, 29(3): 373-376.
[5]	魏鑫, 闫依嫚, 苏可婕, 王思怡, 徐鹏, 陈高红. 门静脉CT血管成像评价肝硬化患者脾肾分流价值研究^*[J]. 实用肝脏病杂志, 2026, 29(3): 385-388.
[6]	徐小虎, 王维, 马秋莲, 于蓉, 许亚春, 祁荣兴. 增强MRI联合血清AFP和PIVKA-II诊断肝细胞癌应用研究^*[J]. 实用肝脏病杂志, 2026, 29(3): 405-408.
[7]	钱梦姣, 孙研俊, 钟瑶. CT和MRI多期动态增强扫描诊断乙型肝炎肝硬化背景下原发性肝癌价值研究^*[J]. 实用肝脏病杂志, 2026, 29(3): 417-420.
[8]	谭春梅, 王庆庆, 刘洁, 范英. 超声造影联合血清AFP和PIVKA-II水平鉴别良恶性肝肿瘤应用价值研究^*[J]. 实用肝脏病杂志, 2026, 29(3): 438-441.
[9]	郝成, 彭勇, 杜霞. 肝移植患者手术前后CTA评估肝脏血供状态研究^*[J]. 实用肝脏病杂志, 2026, 29(3): 442-445.
[10]	程琪, 耿承军, 金晓凤, 徐文韬, 王骁. MRI联合扩散加权成像鉴别诊断不典型肝脓肿与肝内转移癌价值研究^*[J]. 实用肝脏病杂志, 2026, 29(3): 446-449.
[11]	刘静芳, 胡孝娟, 杨卫健. 肝脏局灶性结节性增生磁共振表现特征分析^*[J]. 实用肝脏病杂志, 2026, 29(3): 454-457.
[12]	张靖宇, 王一飞, 马路平. 胆总管结石患者血清sTREM-1、CRP和直接胆红素水平变化及其诊断急性重症胆管炎价值研究^*[J]. 实用肝脏病杂志, 2026, 29(3): 463-466.
[13]	兰国宾, 刘闯, 王浩, 马红玉, 李泽亮, 陈雯, 张文强, 马力丰. Revolution CT多参数能谱成像联合迭代重建技术诊断胆囊炎微小穿孔价值研究^*[J]. 实用肝脏病杂志, 2026, 29(3): 467-470.
[14]	朱琳, 毕娟, 严琪. H-CEUS联合MFI检查鉴别良恶性胆囊息肉样病变价值研究^*[J]. 实用肝脏病杂志, 2026, 29(3): 475-478.
[15]	常静霞, 张丽, 盖琳, 张田龙, 郑爱兰, 郭煜. 瞬时弹性成像联合FIB-4和APRI评估慢性乙型肝炎患者肝纤维化价值研究^*[J]. 实用肝脏病杂志, 2026, 29(2): 183-186.